|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.173 EUR | -4.42% |
|
-1.14% | +17.69% |
Biomark Diagnostics Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was CAD 0.153492 million compared to CAD 0.043933 million a year ago. Net loss was CAD 1.84 million compared to CAD 1.45 million a year ago.
Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.69% | 17.63M | |
| -20.55% | 10.81B | |
| +47.97% | 3.36B | |
| -32.75% | 2.22B | |
| -14.15% | 2.16B | |
| -26.06% | 1.55B | |
| +19.85% | 1.04B | |
| -2.62% | 746M | |
| -31.67% | 425M | |
| -43.88% | 405M |
BIOMARK DIAGNOSTICS INC. 
